Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

Autor: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L, Dis, Biologics Children Rheumatic

Publikováno v: Rheumatology (Oxford, England)
RHEUMATOLOGY
Kearsley-Fleet, L, Beresford, M W, Davies, R, De Cock, D, Baildam, E, Foster, H E, Southwood, T R, Thomson, W, Hyrich, K L & Biologics for Children with Rheumatic Diseases Study (BCRD) 2019, ' Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra ', Rheumatology (Oxford), vol. 58, no. 1, pp. 94-102 . https://doi.org/10.1093/rheumatology/key262

Objectives To investigate real-world short-term outcomes among patients with systemic JIA starting tocilizumab or anakinra. Methods This analysis included all systemic JIA patients within the UK Biologics for Children with Rheumatic Diseases study st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff89dce7fd1afb5b2ae4989dbed4d264
https://doi.org/10.1093/rheumatology/key262

Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children

Autor: Peder Skov Wehner, Mikael Thastum, Nini Kyvsgaard, Torben Stamm Mikkelsen, Karsten Nysom, Troels Herlin, Anne Estmann Christensen

Publikováno v: PLoS ONE, Vol 14, Iss 7, p e0219539 (2019)
Kyvsgaard, N, Mikkelsen, T S, Thastum, M, Christensen, A E, Wehner, P S, Nysom, K & Herlin, T 2019, ' Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children ', PLOS ONE, vol. 14, no. 7, e0219539 . https://doi.org/10.1371/journal.pone.0219539
PLoS ONE

OBJECTIVES: To analyse the internal consistency of an adaption of the methotrexate intolerance severity score (MISS); and to describe and compare the level of methotrexate intolerance evaluated by the MISS in Danish children with juvenile idiopathic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473affef913ea667dffbd16fbcf75b7c
https://doaj.org/article/83e2623aef804332b3f0fb5d9366212c

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries

Autor: Joost F Swart, Ariane Klein, Jens Klotsche, Nicolino Ruperto, Angela Pistorio, Ivan Foeldvari, Francesca Bagnasco, Alessandro Consolaro, Valda Staņēviča, AnnaCarin Horne, Francesca Bovis, Jordi Anton, Elena Tsitsami, Еkaterina Alexeeva, Kirsten Minden, Fabrizio De Benedetti, Sylvia Kamphuis, Nico M Wulffraat, Maria Tracahana, Susan Nielsen, Johannes Peter Haas, Gabriella Giancane, Brigitte Bader-Meunier, Alberto Martini, Michael Hofer, Bo Magnusson, Violeta Panaviene, Gerd Horneff, Laura Marinela Ailioaie

Publikováno v: Arthritis Research & Therapy, 20:285. BioMed Central Ltd.
Arthritis research & therapy, 20(1). BioMed Central
ARTHRITIS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Arthritis research & therapy, vol. 20, no. 1, pp. 285
Arthritis research and therapy, London : BioMed Central Ltd., 2018, vol. 20, iss. 1, art. no. 285, p. [1-11]
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Arthritis Research & Therapy

Background: The availability of methotrexate and the introduction of multiple biological agents have revolutionized the treatment of juvenile idiopathic arthritis (JIA). Several international and national drug registries have been implemented to accu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bcdd4ca65f29113be02f5af41fcde07
https://pure.eur.nl/en/publications/ee7474cb-b162-42a5-983e-d540fc735391

Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression

Autor: Gerald Berthet, Elvira Cannizzaro, Raphael Leuvenink, Andreas Woerner, Walter Baer, Daniela Kaiser, Silke Schroeder, Florence Aeschlimann, Ulrich Heininger, Michael Hofer

Publikováno v: Pediatric Rheumatology Online Journal
Pediatric rheumatology online journal, vol. 14, no. 1, pp. 34

Background To analyze the clinical presentation and complications of varicella zoster virus (VZV) infection in children with rheumatic diseases treated with immunosuppressive medication such as biological disease-modifying antirheumatic drugs (bDMARD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f0779bf6d7183db43bcd16c583b3cbd
http://europepmc.org/articles/PMC4890263